» Articles » PMID: 39143926

Recent Advances in Nanostructured Delivery Systems for Vancomycin

Overview
Specialty Biotechnology
Date 2024 Aug 15
PMID 39143926
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the development of new generations of antibiotics, vancomycin remained as a high-efficacy antibiotic for treating the infections caused by MRSA. Researchers have explored various nanoformulations, aiming to enhance the therapeutic efficacy of vancomycin. Such novel formulations improve the effectiveness of drug cargoes in treating bacterial infections and minimizing the risk of adverse effects. The vast of researches have focuses on enhancing the permeation ability of vancomycin through different biological barriers especially those of gastrointestinal tract. Increasing the drug loading and tuning the drug release from nanocarrier are other important goal for many conducted studies. This study reviews the newest nano-based formulations for vancomycin as a key antibiotic in treating hospitalized bacterial infections.

References
1.
Jensen G, Hodgson D . Opportunities and challenges in commercial pharmaceutical liposome applications. Adv Drug Deliv Rev. 2020; 154-155:2-12. DOI: 10.1016/j.addr.2020.07.016. View

2.
Stogios P, Savchenko A . Molecular mechanisms of vancomycin resistance. Protein Sci. 2020; 29(3):654-669. PMC: 7020976. DOI: 10.1002/pro.3819. View

3.
Vatankhah M, Dadashzadeh S, Mahboubi A, Haeri A, Jandaghi Alaee K, Mostafavi Naeini S . Preparation of multivesicular liposomes for the loco-regional delivery of Vancomycin hydrochloride using active loading method: drug release and antimicrobial properties. J Liposome Res. 2023; 34(1):77-87. DOI: 10.1080/08982104.2023.2220805. View

4.
Muppidi K, Pumerantz A, Wang J, Betageri G . Development and stability studies of novel liposomal vancomycin formulations. ISRN Pharm. 2012; 2012:636743. PMC: 3302012. DOI: 10.5402/2012/636743. View

5.
Mohapatra A, Harris M, Levine D, Ghimire M, Jennings J, Morshed B . Magnetic stimulus responsive vancomycin drug delivery system based on chitosan microbeads embedded with magnetic nanoparticles. J Biomed Mater Res B Appl Biomater. 2017; 106(6):2169-2176. DOI: 10.1002/jbm.b.34015. View